AIMS/HYPOTHESIS: The biological mechanism by which obesity predisposes to insulin resistance is unclear. One hypothesis is that larger adipose cells disturb metabolism via increased lipolysis. While studies have demonstrated that cell size increases in proportion to BMI, it has not been clearly shown that adipose cell size, independent of BMI, is associated with insulin resistance. The aim of this study was to test this widely held assumption by comparing adipose cell size distribution in 28 equally obese, otherwise healthy individuals who represented extreme ends of the spectrum of insulin sensitivity, as defined by the modified insulin suppression test. SUBJECTS AND METHODS: Subcutaneous periumbilical adipose tissue biopsy samples were fixed in osmium tetroxide and passed through the Beckman Coulter Multisizer to obtain cell size distributions. Insulin sensitivity was quantified by the modified insulin suppression test. Quantitative real-time PCR for adipose cell differentiation genes was performed for 11 subjects. RESULTS: All individuals exhibited a bimodal cell size distribution. Contrary to expectations, the mean diameter of the larger cells was not significantly different between the insulin-sensitive and insulin-resistant individuals. Moreover, insulin resistance was associated with a higher ratio of small to large cells (1.66 +/- 1.03 vs 0.94 +/- 0.50, p = 0.01). Similar cell size distributions were observed for isolated adipose cells. The real-time PCR results showed two- to threefold lower expression of genes encoding markers of adipose cell differentiation (peroxisome proliferator-activated receptor gamma1 [PPARgamma1], PPARgamma2, GLUT4, adiponectin, sterol receptor element binding protein 1c) in insulin-resistant compared with insulin-sensitive individuals. CONCLUSIONS/ INTERPRETATION: These results suggest that after controlling for obesity, insulin resistance is associated with an expanded population of small adipose cells and decreased expression of differentiation markers, suggesting that impairment in adipose cell differentiation may contribute to obesity-associated insulin resistance.
AIMS/HYPOTHESIS: The biological mechanism by which obesity predisposes to insulin resistance is unclear. One hypothesis is that larger adipose cells disturb metabolism via increased lipolysis. While studies have demonstrated that cell size increases in proportion to BMI, it has not been clearly shown that adipose cell size, independent of BMI, is associated with insulin resistance. The aim of this study was to test this widely held assumption by comparing adipose cell size distribution in 28 equally obese, otherwise healthy individuals who represented extreme ends of the spectrum of insulin sensitivity, as defined by the modified insulin suppression test. SUBJECTS AND METHODS: Subcutaneous periumbilical adipose tissue biopsy samples were fixed in osmium tetroxide and passed through the Beckman Coulter Multisizer to obtain cell size distributions. Insulin sensitivity was quantified by the modified insulin suppression test. Quantitative real-time PCR for adipose cell differentiation genes was performed for 11 subjects. RESULTS: All individuals exhibited a bimodal cell size distribution. Contrary to expectations, the mean diameter of the larger cells was not significantly different between the insulin-sensitive and insulin-resistant individuals. Moreover, insulin resistance was associated with a higher ratio of small to large cells (1.66 +/- 1.03 vs 0.94 +/- 0.50, p = 0.01). Similar cell size distributions were observed for isolated adipose cells. The real-time PCR results showed two- to threefold lower expression of genes encoding markers of adipose cell differentiation (peroxisome proliferator-activated receptor gamma1 [PPARgamma1], PPARgamma2, GLUT4, adiponectin, sterol receptor element binding protein 1c) in insulin-resistant compared with insulin-sensitive individuals. CONCLUSIONS/ INTERPRETATION: These results suggest that after controlling for obesity, insulin resistance is associated with an expanded population of small adipose cells and decreased expression of differentiation markers, suggesting that impairment in adipose cell differentiation may contribute to obesity-associated insulin resistance.
Authors: I Zavaroni; P Gasparini; A I Barilli; P Massironi; C Campanini; M Carantoni; R Delsignore; G M Reaven Journal: Metabolism Date: 2000-04 Impact factor: 8.694
Authors: Xiaolin Yang; Per-Anders Jansson; Ivan Nagaev; Maia M Jack; Eugenia Carvalho; Katharina Stibrant Sunnerhagen; Margaret C Cam; Samuel W Cushman; Ulf Smith Journal: Biochem Biophys Res Commun Date: 2004-05-14 Impact factor: 3.575
Authors: Yourka D Tchoukalova; Susanne B Votruba; Tamara Tchkonia; Nino Giorgadze; James L Kirkland; Michael D Jensen Journal: Proc Natl Acad Sci U S A Date: 2010-10-04 Impact factor: 11.205
Authors: Oleg Varlamov; Romel Somwar; Anda Cornea; Paul Kievit; Kevin L Grove; Charles T Roberts Journal: Am J Physiol Endocrinol Metab Date: 2010-06-22 Impact factor: 4.310
Authors: Morvarid Kabir; Darko Stefanovski; Isabel R Hsu; Malini Iyer; Orison O Woolcott; Dan Zheng; Karyn J Catalano; Jenny D Chiu; Stella P Kim; Lisa N Harrison; Viorica Ionut; Maya Lottati; Richard N Bergman; Joyce M Richey Journal: Obesity (Silver Spring) Date: 2011-08-11 Impact factor: 5.002
Authors: Bjorn Eliasson; Ulf Smith; Shawn Mullen; Samuel W Cushman; Arthur S Sherman; Jian Yang Journal: Adipocyte Date: 2014-12-10 Impact factor: 4.534
Authors: James E N Minchin; Ingrid Dahlman; Christopher J Harvey; Niklas Mejhert; Manvendra K Singh; Jonathan A Epstein; Peter Arner; Jesús Torres-Vázquez; John F Rawls Journal: Proc Natl Acad Sci U S A Date: 2015-03-23 Impact factor: 11.205
Authors: Daniel A Dumesic; Alin L Akopians; Vanessa K Madrigal; Emmanuel Ramirez; Daniel J Margolis; Manoj K Sarma; Albert M Thomas; Tristan R Grogan; Rasha Haykal; Tery A Schooler; Bette L Okeya; David H Abbott; Gregorio D Chazenbalk Journal: J Clin Endocrinol Metab Date: 2016-08-29 Impact factor: 5.958
Authors: Yang Zhang; Alexander J Federation; Soomin Kim; John P O'Keefe; Mingyue Lun; Dongxi Xiang; Jonathan D Brown; Matthew L Steinhauser Journal: J Clin Invest Date: 2018-10-02 Impact factor: 14.808